KLKB1 and infection: After 3 weeks of treatment (designated t = 0 in the infection experiments described below), Klkb1 mRNA expression in the liver was inhibited by over 80% in PKK ASO‐treated mice compared with mice treated with Ctrl ASO (Figure 1B).